Summary by Futu AI
Mark E. Dmytruk, associated with Ginkgo Bioworks Holdings, Inc. [DNA], completed a series of transactions involving the company's Class A Common Stock. On February 1, 2024, Dmytruk acquired a total of 85,208 shares through the exercise of derivative securities. The following day, he sold 39,569 shares in the open market at a price of $1.208 per share. After these transactions, Dmytruk's direct holdings in Ginkgo Bioworks totaled 761,737 shares. The total market value of the disposed shares amounted to $47,799.35.